Russell Investments Group
XBI icon

Russell Investments Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Russell Investments Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.6K Sell
161
-31
-16% -$4.19K ﹤0.01% 3767
2026
Q1 		$24.6K Buy
192
+58
+43% +$7.24K ﹤0.01% 3558
2025
Q4 		$16.4K Buy
134
+4
+3% +$459 ﹤0.01% 3681
2025
Q3 		$13K Buy
+130
New +$11.7K ﹤0.01% 3723
2025
Q2 		– Sell
-88
Closed -$7.14K – 3967
2025
Q1 		$7.14K Sell
88
-56
-39% -$5K ﹤0.01% 3296
2024
Q4 		$13K Buy
144
+125
+658% +$12.1K ﹤0.01% 3091
2024
Q3 		$1.88K Sell
19
-2
-10% -$197 ﹤0.01% 3389
2024
Q2 		$1.95K Buy
+21
New +$1.88K ﹤0.01% 3351
2018
Q2 		– Sell
-50,446
Closed -$4.43M – 2972
2018
Q1 		$4.43M Sell
50,446
-4,022
-7% -$367K 0.01% 1426
2017
Q4 		$4.7M Buy
54,468
+4,109
+8% +$344K 0.01% 1383
2017
Q3 		$4.36M Buy
50,359
+1,218
+2% +$97.6K 0.01% 1337
2017
Q2 		$3.79M Buy
49,141
+18,746
+62% +$1.33M 0.01% 1375
2017
Q1 		$2.11M Buy
30,395
+4,079
+16% +$274K ﹤0.01% 1735
2016
Q4 		$1.57M Buy
+26,316
New +$1.62M ﹤0.01% 1932

Other funds holding XBI

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

Russell Investments Group's XBI Position: Q2 2026 in Review

Russell Investments Group reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 16% in Q2 2026, selling an estimated $4.19K and leaving 161 shares worth $25.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3767.

Russell Investments Group first reported a position in XBI in Q4 2016 and has held it in 14 quarters since. The position peaked at $4.7M in Q4 2017. 551 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Russell Investments Group held 161 shares of State Street SPDR S&P Biotech ETF worth $25.6K as of Q2 2026.
  • Russell Investments Group sold 31 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $4.19K.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3767 holding.
  • Russell Investments Group first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and has held it in 14 quarters since.
  • Russell Investments Group's State Street SPDR S&P Biotech ETF position peaked at $4.7M in Q4 2017.
  • 551 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.